Chemical Structure : BGB-16673
Catalog No.: PC-21567Not For Human Use, Lab Use Only.
BGB-16673 is an orally available heterobifunctional BTK PROTAC degrader that binds to BTK and E3 ligase, degrades wildtype BTK and multiple mutant forms via ubiquitination.
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
BGB-16673 is an orally available heterobifunctional BTK PROTAC degrader that binds to BTK and E3 ligase, degrades wildtype BTK and multiple mutant forms via ubiquitination.
BGB-16673 exhibits high potency on clinically relevant BTK mutants resistant to covalent and non-covalent BTK inhibitors in cancer cells in vitro.
BGB-16673 drives complete tumor regression of lymphoma xenograft models expressing wildtype or BTK mutations resistant to covalent and non-covalent inhibitors.
BGB-16673 presents longer duration of response than BTK inhibitors in BTK wildtype and C481S mutant-expressing lymphoma xenograft models.
M.Wt | 850.04 | |
Formula | C48H55N11O4 | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
1. John F. Seymour, et al. Blood (2023) 142 (Supplement 1): 4401.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright